Related Experiment Videos
Postmenopausal hormone replacement therapy and cardiovascular disease
C U Chae1, P M Ridker, J E Manson
1Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA 02215-0214, USA.
Thrombosis and Haemostasis
|July 1, 1997
Summary
Hormone replacement therapy (HRT) may offer cardiovascular protection in postmenopausal women by improving lipid profiles and vascular function. However, more large-scale trials are needed to confirm benefits and assess risks, especially for combined therapies.
Area of Science:
- Cardiology
- Endocrinology
- Women's Health
Background:
- Cardiovascular disease is a primary cause of death in postmenopausal women.
- Hormone replacement therapy (HRT) is investigated for potential cardioprotective effects.
- Epidemiologic studies and trials on lipid subfractions suggest a link between HRT and reduced coronary heart disease risk.
Purpose of the Study:
- To review the potential cardioprotective role of hormone replacement therapy (HRT) in postmenopausal women.
- To explore the biological mechanisms underlying estrogen's effects on cardiovascular health.
- To identify gaps in current research and the need for further clinical trials.
Main Methods:
- Review of epidemiologic studies and randomized trials.
- Analysis of estrogen's effects on lipid profiles (HDL, LDL).
- Examination of potential biological mechanisms including vascular function, oxidative stress, and insulin sensitivity.
Main Results:
- Estrogen positively impacts lipid profiles, increasing HDL and decreasing LDL by approximately 10% each.
- Potential benefits observed in vascular function, oxidative status, vasodilation, and insulin sensitivity.
- Estrogen replacement therapy shows reduced atherosclerosis in animal models.
Conclusions:
- While observational data and small trials suggest HRT may be cardioprotective, most evidence relies on intermediate markers, not clinical events.
- The net effects of HRT on coagulation and fibrinolysis remain unclear.
- Large-scale randomized trials are essential to definitively establish the role of estrogen replacement therapy, considering combined therapies and the overall benefit-risk balance.